Clinical Laboratory, The Second People's Hospital of Wuhu City, Wuhu, People's Republic of China.
Department of Laboratory Medicine, The Third Xiangya Hospital, Xiangya School of Medicine, Central South University, Changsha, People's Republic of China.
FASEB J. 2023 Jul;37(7):e23055. doi: 10.1096/fj.202201628RR.
Tumor cells are known for being able to evade immune system surveillance, a hallmark of malignancy. Complicated immune escape mechanisms in the tumor microenvironment (TME) provide favorable conditions for tumor invasion, metastasis, treatment resistance, and recurrence. Epstein-Barr virus (EBV) infection is closely related to the pathogenesis of nasopharyngeal carcinoma (NPC), and the co-existence of EBV-infected NPC cells and tumor-infiltrating lymphocytes represents a distinctive, highly heterogeneous, and suppressive TME that supports immune escape and promotes tumorigenesis. Understanding the complex interaction between EBV and NPC host cells and focusing on the immune escape mechanism of TME may help to identify specific immunotherapy targets and to develop effective immunotherapy drugs.
肿瘤细胞能够逃避免疫系统的监测,这是恶性肿瘤的一个标志。肿瘤微环境(TME)中复杂的免疫逃逸机制为肿瘤的侵袭、转移、治疗耐药和复发提供了有利条件。EB 病毒(EBV)感染与鼻咽癌(NPC)的发病机制密切相关,EBV 感染的 NPC 细胞与肿瘤浸润淋巴细胞共存,构成了一个独特的、高度异质性的、抑制性的 TME,支持免疫逃逸并促进肿瘤发生。了解 EBV 与 NPC 宿主细胞之间的复杂相互作用,并关注 TME 的免疫逃逸机制,可能有助于确定特定的免疫治疗靶点,并开发有效的免疫治疗药物。